Price, availability and affordability : an international comparison of chronic disease medicines

This is an analysis of the data collected in recent surveys of originator and generic medicines used to treat chronic diseases, and demonstrates that the price, availability and affordability are optimal for neither product types in most of the countries surveyed. The report is intended to be used by policy-makers and programme managers responsible for pricing, price regulation, procurement and other regulatory affairs related to chronic diseases, and can also be used for civil society groups wanting to advocate for pricing policies to make medicines more affordable and available